Looking to buy Retatrutide in Europe? Compare vials, pen and bundles with clear specifications, available batch documentation and EU delivery.
Buy Retatrutide: choose your format
Compare live prices and available formats. For vials and variable products, choose the required strength first.
In stock
Retatrutide vials 10–50 mg
Choose the required strength on the product page.
In stock
Retatrutide pen
Review the available pen configuration and product specifications.
In stock
Retatrutide bundle 3 × 20 mg
Three separate vials in one value bundle.
In stock
Retatrutide Research Vault 8 × 20 mg
Eight separate vials for larger research projects.
Research use only: for controlled laboratory research only; not for human or veterinary consumption.
Important before ordering
- For controlled laboratory research only.
- Not for human or veterinary consumption.
- Do not inject, ingest or use for diagnosis, treatment or prevention.
- Retatrutide is experimental and is not an approved medicine.
What is retatrutide?
Retatrutide (LY3437943) is an experimental molecule studied in clinical research as an agonist of the GIP, GLP-1 and glucagon receptors. Developer Eli Lilly explicitly describes retatrutide as investigational.
Research registrations can be checked via ClinicalTrials.gov; current development information is available from Eli Lilly. Research results do not establish that a separately supplied research product is safe, effective or suitable for human use.
Batch documentation and quality control
Before purchasing, check which batch documentation is available for the selected product. A COA or analysis report is only meaningful when it can be linked to the supplied batch and its method, date and results can be verified. Documentation is not presented as medical approval.
Read how to read a COA and our page about laboratory testing and quality control. If a current batch document is not visible, request it before ordering through contact.
Storage and packaging
Store research material according to the product specifications and documentation for the relevant batch. Read the current information about peptide storage.
Delivery in the EU
Orders are processed within the EU for supported destinations. Current delivery times, methods, costs and return terms are listed under shipping and returns.
Transparent ordering at Peptivora
Before checkout, verify the product specifications, batch information, stock and total price. Read about Peptivora, contact, shipping and returns and the terms and conditions.
Frequently asked questions about buying Retatrutide
Is retatrutide an approved medicine?
No. Retatrutide is an experimental compound in clinical research and must not be regarded or used as an approved medicine.
Is this product intended for weight loss or treating a condition?
No. The research products offered are intended exclusively for controlled laboratory research, not for human consumption, self-medication, weight loss, diagnosis or treatment.
Which research formats are available?
Peptivora lists vials and several research bundles; a research-pen presentation may also be available. Check the product pages for current options and stock.
Will I receive a COA with my order?
Only rely on a COA when it is actually available for the relevant batch. Contact us before ordering if you cannot verify the documentation.
Does Peptivora deliver within the EU?
Peptivora processes deliveries to supported EU destinations. Check the shipping page and checkout options for your address.
Where can I read more about the research?
Read what is retatrutide? en retatrutide versus tirzepatide. These articles do not constitute medical advice.